H. pylori infection. our experience with the quadruple and triple therapy as first pharmacologic approach
Ierfone, N.; Stragapede, R.A.; Angelini, R.; Pontone, S.; Di Fulvio, A.; Standoli, M.; Pontone, P.
Il Giornale di Chirurgia 22(4): 150-152
2001
ISSN/ISBN: 0391-9005 PMID: 11370224 Document Number: 539261
For now the most used pharmacological treatment of first instance to eradication of Hp foresees utilization of triple therapy (PPI + two antibiotics). In our study we have compared this kind of treatment with the quadruple therapy (PPI + three antibiotics), that have showed a taller percentage of eradication at the end of first therapeutical cycle with a shorter time and lower price of treatment.
Document emailed within 1 workday
Related Documents
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307Brzozowski, T.; Konturek, P.C.; Kwiecien, S.; Konturek, S.J.; Pajdo, R.; Drozdowicz, D.; Ptak, A.; Pawlik, M.; Stachura, J.; Pawlik, W.W.; Hahn, E.G. 2003: Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 54(1): 33-51
Cui, M.; Hu, F.; Jiang, H.; Zheng, X. 2002: Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection Zhonghua Yi Xue Za Zhi 82(18): 1245-1248
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Adamek, R.J.; Opferkuch, W.; Wegener, M. 1995: Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection American Journal of Gastroenterology 90(1): 168-169
Shirai, N.; Furuta, T. 2002: High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism Nihon Rinsho. Japanese Journal of Clinical Medicine 60 Suppl. 2: 439-444
Fattahi, E.; Motamedi, R.; Nayebi, A.R.M.; Rezazadeh, H.; Shakir, A. 2004: Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: a randomized, open study Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 23(4): 154
Kumar, D.; Ahuja, V.; Dhar, A.; Sharma, M.P. 2001: Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 20(5): 191-194
Tursi, A.; Cammarota, G.; Papa, A.; Montalto, M.; Veneto, G.; Capelli, G.; Cuoco, L.; Branca, G.; Fedeli, G.; Gasbarrini, G. 1996: One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection Hepato-Gastroenterology 43(10): 859-862
Köksal, A.S.; Onder, F.O.ğu.; Torun, S.; Parlak, E.; Sayilir, A.; Tayfur, O.ü; Yildiz, H.; Ozbalci, G.ök.S.çu.; Kayaçetin, E.ğr. 2013: Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance Acta Gastro-Enterologica Belgica 76(1): 34-37
Gao, W.; Cheng, H.; Hu, F.-l.; Lü, N.-h.; Xie, Y.; Sheng, J.-q.; Xu, J.-m.; Zhang, L.-x.; Zhang, L.; Chen, Y.; Zhang, Z.-y.; Zhang, G.-x.; Cui, M.-h.; Yang, G.-b.; Gao, H.-j.; Yang, L. 2012: Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study Zhonghua Yi Xue Za Zhi 92(30): 2108-2112
Treiber, G.; Wittig, J.; Ammon, S.; Walker, S.; van Doorn, L-Jan.; Klotz, U. 2002: Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study) Archives of Internal Medicine 162(2): 153-160
Sanfélix Genovés, J.; Pereiró Berenguer, I.; Jimeno Bernard, R.; García Tell, G.; Navarro Pérez, J.; Bonet Pla, A.; Ballester Belenguer, J. 1998: Helicobacter pylori: 6-day triple therapy in duodenal ulcer Atencion Primaria 21(8): 517-521
Ren, Q.; Ma, B.; Yang, K.; Yan, X. 2010: Lafutidine-based triple therapy for Helicobacter pylori eradication Hepato-Gastroenterology 57: 102-103
Figueroa, G.; Acuña, R.; Troncoso, M.; Portell, D.P.; Toledo, M.S.; Albornoz, V.; Vigneaux, J. 1996: Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients American Journal of Gastroenterology 91(7): 1395-1399
Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1993: Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease Medizinische Klinik 88(5): 297-299
Thong-Ngam, D.; Tangkijvanich, P.; Treeprasertsuk, S.; Wisedopas, N.; Kullavanijaya, P. 2002: Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori Journal of the Medical Association of Thailand 85(10): 1054-1059
Flores, S.; Opazo, H.; Valderrama, D.; Aguilera, R.; Marchese, A.; Valderrama, S. 2000: Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori Revista Medica de Chile 128(5): 509-512
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Coimbra-Filho, A.F.; Rocha, N.D.; Pissinatti, A. 1976: Quadruple pregnancy of triple-hybrids in duplo-hybrid Callithrix (Callitrichidae, primates) Revista Brasileira de Biologia 36(6): 675-681